spacer
home > pmps > spring 2017 > breathing new life into asthma care
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing New Life into Asthma Care

Smart inhalers represent a convergence of several market forces, technology and trends that are poised to change asthma care and improve outcomes. They are part of an overall smart device trend in mHealth focused at the multibillion dollar asthma industry. One of the biggest culprits of poor patient outcomes in asthma care is taking a reactive rather than proactive approach to treatment, and poor adherence of care plans among patients.

Why Smart Inhalers?

The technology around these devices can offer a number of benefits to both the patient and the healthcare provider, such as making it easier to remember to take prevention medicine and report symptoms, which can lead to improved disease self-management and adherence rates. Other benefits include their ability to collect actionable data and patients being able to identify their own patterns. Sixty-seven percent of patients do not take their inhalers correctly. With smart sensors built into these devices, the patient is told if they have shaken it correctly or not.

The sensors can also detect the quality of inhalation, which is very important when it comes to judging the effectiveness of the medication. Collection of key data, recognising patterns and potential aggravators to severe asthma attacks can help reduce costly readmissions and result in improved disease management as well as adherence rates. In the future, a convergence of trends and technologies will put smart inhalers and their accompanying data at the epicentre of managing asthma care. To this end, some companies

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
An engineer at heart and entrepreneur by trade, Ali Moiyed is founder and Chief Executive Officer of Aerobit Health. Living with asthma himself, he launched the digital healthcare company in July 2016.
spacer
Ali Moiyed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

E Ink and Faubel Unveil the Med Label to Revolutionize the Clinical Trial Supply Chain

E Ink® Holdings, "E Ink" (8069.TW), the leading innovator of electronic ink technology and Faubel & Co. Nachf. GmbH, a proven supplier to the pharmaceutical and chemical industry, announced the availability of the Faubel-Med® Label, a smart label for investigational medicinal products. The Med Label features E Ink’s low-voltage film technology, bringing display modules and new system designs to pharmaceutical packaging.
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

Clinical Trial Supply West Coast 2018

23-24 May 2018, Burlingame, CA

Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement